Literature DB >> 16092795

The role of inflammation in the pathogenesis of acne and acne scarring.

Diana B Holland1, Anthony H T Jeremy.   

Abstract

Evidence now supports a pivotal role for cellular inflammatory events at all stages of acne lesion development, from preclinical initiation to clinical presentation of active lesions through to resolution. The emphasis has moved from acne as a primarily hyperproliferative disorder of the sebaceous follicle to that of an inflammatory skin disorder. However, although the sequence of events leading to lesion formation has become clearer, the triggers for initiation remain speculative. The development of noninvasive techniques to detect preclinical "acne-prone" follicles is essential before triggers for initiation can be defined. Finally, the differences highlighted in the inflammatory profiles of inflamed lesions from patients who scar, as compared with other nonscarring acne patients reinforces the view that acne is a disorder, which embraces a number of pathologies.

Entities:  

Mesh:

Year:  2005        PMID: 16092795     DOI: 10.1016/j.sder.2005.03.004

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  10 in total

1.  Evaluating the Efficacy of Photodynamic Therapy with 20% Aminolevulinic Acid and Microdermabrasion as a Combination Treatment Regimen for Acne Scarring: A Split-face, Randomized, Double-blind Pilot Study.

Authors:  Rita V Linkner; Shelbi Jim On; Madelaine Haddican; Giselle Singer; Helen Shim-Chang
Journal:  J Clin Aesthet Dermatol       Date:  2014-05

2.  Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier?

Authors:  Diane Thiboutot; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-02

3.  Serum 25-hydroxy vitamin D levels in patients with acne vulgaris and its association with disease severity.

Authors:  Parviz Toossi; Zahra Azizian; Hassan Yavari; Tannaz Hoseinzade Fakhim; Seyed Hadi Sadat Amini; Ramin Enamzade
Journal:  Clin Cases Miner Bone Metab       Date:  2015-12-29

4.  Clinical implications of lipid peroxidation in acne vulgaris: old wine in new bottles.

Authors:  Whitney P Bowe; Alan C Logan
Journal:  Lipids Health Dis       Date:  2010-12-09       Impact factor: 3.876

Review 5.  Adult-onset acne: prevalence, impact, and management challenges.

Authors:  Marco A Rocha; Ediléia Bagatin
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-02-01

6.  Double-blind, randomized controlled trial comparing the use of microneedling alone versus chemical peeling alone versus a combination of microneedling and chemical peeling in the treatment of atrophic post-acne scars. An assessment of clinical effectiveness and patients' quality-of-life.

Authors:  Agata Pakla-Misiur; Marcelina Grochowiec; Aleksandra Lesiak; Igor A Bednarski
Journal:  Postepy Dermatol Alergol       Date:  2021-09-17       Impact factor: 1.837

7.  Acne vulgaris, mental health and omega-3 fatty acids: a report of cases.

Authors:  Mark G Rubin; Katherine Kim; Alan C Logan
Journal:  Lipids Health Dis       Date:  2008-10-13       Impact factor: 3.876

8.  Dramatic improvement of severe acne pustolosa after adalimumab in a patient with ulcerative colitis.

Authors:  Antonio Rispo; Dario Musto; Nicola Imperatore; Anna Testa; Matilde Rea; Fabiana Castiglione
Journal:  Clin Case Rep       Date:  2016-02-25

Review 9.  Profile of clindamycin phosphate 1.2%/benzoyl peroxide 3.75% aqueous gel for the treatment of acne vulgaris.

Authors:  Tuyet A Nguyen; Lawrence F Eichenfield
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-10-29

10.  Microneedling in the treatment of atrophic scars: A systematic review of randomised controlled trials.

Authors:  Irma Bernadette S Sitohang; Sondang Aemilia Pandjaitan Sirait; Jose Suryanegara
Journal:  Int Wound J       Date:  2021-02-03       Impact factor: 3.315

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.